IRADIMED (IRMD) Financial Statements & Analysis

IRADIMED (IRMD) Income Statement

IRADIMED reported revenue of $83.81M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 14.4% from $73.24M a year earlier. Net income was $22.48M, up 16.9% year over year, a net margin of 26.8%. Gross margin was 76.7% and operating margin 31.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $20.47M, up 0.3% from the same quarter a year earlier.

IRADIMED Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

IRADIMED CORPORATION income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	83.81	73.24	65.56	53.30	41.81	31.72	38.52	30.44	23.08
Cost of Revenue	19.49	16.89	15.40	12.02	9.76	8.14	8.82	7.21	5.57
Gross Profit	64.32	56.35	50.16	41.28	32.05	23.57	29.70	23.23	17.51
Operating Expenses
Research & Development	2.95	2.80	2.86	2.24	1.91	1.90	1.43	1.52	1.72
Selling, General & Administrative	35.23	31.59	27.26	23.41	20.33	22.43	19.62	15.71	14.50
Operating Expenses	38.18	34.39	30.12	25.65	22.23	24.33	21.05	17.22	16.23
Operating Income	26.15	21.97	20.04	15.63	9.82	-0.76	8.65	6.00	1.29
Other Income/Expense
Interest Income	2.01	2.19	1.86	0.58	0.03	0.13	0.39	0.24	0.12
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	2.21	2.31	-0.16	0.55	0.02	0.14	0.40	0.19	0.11
Income
Income Before Tax	28.36	24.28	21.74	16.18	9.84	-0.62	9.04	6.20	1.40
Income Tax Expense	5.88	5.04	4.55	3.35	0.51	-1.99	-0.59	-0.11	0.90
Net Income	22.48	19.23	17.19	12.83	9.33	1.37	9.63	6.30	0.50
Net Income - Continuous Operations	22.48	19.23	17.19	12.83	9.33	1.37	9.63	6.30	0.50
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	27.31	22.78	20.80	16.30	11.24	0.58	9.89	7.11	2.59
EBIT	26.15	21.97	20.04	15.63	9.82	-	-	-	-
Depreciation & Amortization	1.05	0.82	0.77	0.67	1.41	1.34	1.24	0.56	0.45
Earnings Per Share
Basic EPS	2.00	2.00	1.00	1.00	1.00	-	1.00	1.00	-
Diluted EPS	2.00	2.00	1.00	1.00	1.00	-	1.00	1.00	-
Basic Shares Outstanding	12.72	12.67	12.60	12.56	12.35	12.12	11.28	12.11	10.64
Diluted Shares Outstanding	12.85	12.78	12.72	12.64	12.59	12.44	12.28	12.11	11.72

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About IRADIMED Financial Statements

What was IRADIMED's revenue in fiscal 2025?

IRADIMED reported revenue of $83.81M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 14.4% from $73.24M a year earlier.

Is IRADIMED profitable?

Yes. IRADIMED earned net income of $22.48M in fiscal 2025, a net margin of 26.8%. In fiscal 2024 it earned $19.23M.

What is IRADIMED's operating margin?

IRADIMED's operating income was $26.15M on revenue of $83.81M in fiscal 2025, an operating margin of 31.2%, compared with 30.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition